Table 3.
Reporting Quality of 46 Randomized Controlled Trials According to Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA)
| Intervention | Description of item | No. trials eligible to the principle | Percentage | |
|---|---|---|---|---|
| (1) Acupuncture rationale | 1 | 1a) Style of acupuncture | 46 | 100.00% | 
| 1b) Rationale for treatment (e.g., syndrome patterns, segmental levels, trigger points) and individualization if used | 46 | 100.00% | ||
| 1c) Literature sources to justify rationale | 33 | 71.74% | ||
| (2) Needling details | 2 | 2a) Points used (uni/bilateral) | 46 | 100.00% | 
| 2b) Numbers of needles inserted | 24 | 52.17% | ||
| 2c) Depths of insertion (e.g., cun or tissue level) | 21 | 45.65% | ||
| 2d) Responses elicited (e.g., de qi or twitch response) | 21 | 45.65% | ||
| 2e) Needle stimulation (e.g., manual or electrical) | 27 | 58.70% | ||
| 2f) Needle retention time | 46 | 100.00% | ||
| 2g) Needle type (gauge, length, and manufacturer or material) | 25 | 54.35% | ||
| (3) Treatment regimen | 3 | 3a) Number of treatment sessions | 46 | 100.00% | 
| 3b) Frequency of treatment | 46 | 100.00% | ||
| (4) Co-interventions | 4 | 4a) Other interventions (e.g., moxibustion, cupping, herbs, exercises, lifestyle advice) | 46 | 100.00% | 
| (5) Practitioner background | 5 | 5a) Duration of relevant training | 2 | 4.35% | 
| 5b) Length of clinical experience | 2 | 4.35% | ||
| 5c) Expertise in specific condition | 3 | 6.52% | ||
| (6) Control intervention(s) | 6 | 6a) Intended effect of control intervention and its appropriateness to research question and, if appropriate, blinding of participants (e.g., active comparison, minimally active penetrating or nonpenetrating sham, inert) | 11 | 23.91% | 
| 6b) Explanations given to patients of treatment and control interventions | 7 | 15.22% | ||
| 6c) Details of control intervention (precise description, as for item 2 above, and other items if different) | 12 | 26.09% | ||
| 6d) Sources that justify choice of control | 7 | 15.22% |